Pancoast tumor epidemiology and demographics

Revision as of 23:22, 3 March 2018 by Mazia Fatima (talk | contribs)
Jump to navigation Jump to search


Pancoast tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pancoast tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pancoast tumor epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pancoast tumor epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pancoast tumor epidemiology and demographics

CDC onPancoast tumor epidemiology and demographics

Pancoast tumor epidemiology and demographics in the news

Blogs on Pancoast tumor epidemiology and demographics

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pancoast tumor epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]

Overveiw

Pancoast tumors are a rare type of non-small cell lung cancers (NSCLC), account for fewer than 5% of all lung cancers. In the United States, the age-adjusted prevalence of pancoast tumor is estimated to be 5 per 100,000. The prevalence of lung cancer significantly increases among smokers and individuals with chronic exposure to risk factors for lung cancer. In 2014 the incidence of Pancoast tumor was approximately 3 cases per 100,000. Lung cancer is more common in older adults. It is rare in people under age 45. Males are thought to be more predisposed to the development of lung cancer. This gender discrepancy is often attributed to the historically increased rate of smoking among males compared to females. The male to female ratio for the incidence of lung cancer is approximately 1.4 to 1. There is no racial predilection for Pancoast tumor. The incidence of lung cancer is lower in developing countries than in developed countries. It is unknown whether this decreased incidence is due to decreased cancer rates or decreased detection rates. Western Europe and the U.S. have the highest incidence of lung cancer.

Epidemiology and Demographics

Pancoast tumors are a rare type of non-small cell lung cancers (NSCLC), account for fewer than 5% of all lung cancers.[1][2][1][3][4][5]

Prevalence

Incidence

Age

Gender

  • Males are thought to be more predisposed to the development of lung cancer. This gender discrepancy is often attributed to the historically increased rate of smoking among males compared to females.
  • The male to female ratio for the incidence of lung cancer is approximately 1.4 to 1.

Race

  • There is no racial predilection for Pancoast tumor.

Developing Countries

  • The incidence of lung cancer is lower in developing countries than in developed countries. It is unknown whether this decreased incidence is due to decreased cancer rates or decreased detection rates.

Developed Countries

  • Western Europe and the U.S. have the highest incidence of lung cancer.

References

  1. 1.0 1.1 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
  2. Siegel, Rebecca; Ma, Jiemin; Zou, Zhaohui; Jemal, Ahmedin (2014). "Cancer statistics, 2014". CA: A Cancer Journal for Clinicians. 64 (1): 9–29. doi:10.3322/caac.21208. ISSN 0007-9235.
  3. "Gender in lung cancer and smoking research" (PDF). World Health Organization. 2004. Retrieved 2007-05-26.
  4. Ginsberg RJ, Martini N, Zaman M, Armstrong JG, Bains MS, Burt ME, McCormack PM, Rusch VW, Harrison LB (June 1994). "Influence of surgical resection and brachytherapy in the management of superior sulcus tumor". Ann. Thorac. Surg. 57 (6): 1440–5. PMID 8010786.
  5. Johnson DE, Goldberg M (June 1997). "Management of carcinoma of the superior pulmonary sulcus". Oncology (Williston Park, N.Y.). 11 (6): 781–5, discussion 785–6. PMID 9189936.

Template:WH Template:WS